Lipum AB (publ) announced that the Board of Directors has appointed Ola Sandborgh as new Chief Executive Officer, effective from 1 December 2023. Ola Sandborgh has more than three decades of experience from the pharmaceutical industry where he has worked in leading roles in different commercial, innovation and business development positions in companies such as Pfizer, Sanofi Pasteur MSD and, most recently, as Vice President Immunology & Specialty Care at Swedish Orphan Biovitrum (Sobi). Ola has been leading global cross functional teams as well as coordinating partnerships with numerous of companies, contributing in several early to late-stage development projects and acquiring a significant experience within M&A ´s and DD ´s. Einar Pontén is leaving his executive role as CEO upon his own request, but still very dedicated he will take a part time business development role to facilitate a smooth transfer of responsibilities and to support further activities.